ProfileGDS4095 / 219359_at
TitleTamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
OrganismHomo sapiens


SRC1 knockdown control tamoxifen untreated tamoxifen untreated GSM709767 GSM709769 GSM709765 GSM709771 GSM709772 GSM709775 GSM709764 GSM709766 GSM709768 GSM709777 GSM709770 GSM709773 GSM709774 GSM709776 61% 60% 60% 61% 62% 60% 59% 60% 62% 60% 61% 59% 60% 62% sort by genotype/variation sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM709767LY2 SRC1-siRNA tamoxifen treated rep15.0909761
GSM709769LY2 SRC1-siRNA tamoxifen treated rep34.8574760
GSM709765LY2 SRC1-siRNA untreated rep34.8069860
GSM709771LY2 SRC1-siRNA untreated rep14.8978661
GSM709772LY2 SRC1-siRNA untreated rep25.1322362
GSM709775LY2 SRC1-siRNA untreated rep44.8517760
GSM709764LY2 control-siRNA tamoxifen treated rep24.6206559
GSM709766LY2 control-siRNA tamoxifen treated rep34.8022860
GSM709768LY2 control-siRNA tamoxifen treated rep15.1822962
GSM709777LY2 control-siRNA tamoxifen treated rep44.7520360
GSM709770LY2 control-siRNA untreated rep35.0023661
GSM709773LY2 control-siRNA untreated rep14.6121159
GSM709774LY2 control-siRNA untreated rep24.699560
GSM709776LY2 control-siRNA untreated rep45.0643762